Eden Bioscience, the agricultural biotechnology company that developed a crop-boosting product called Messenger, said today it has decided to shut down for good and liquidate its assets. The Woodinville, WA-based company (NASDAQ: [[ticker:EDEN]]) sold its proprietary harpin protein technology in February 2007 to Pittsburgh-based Plant Health Care. Since then, Eden has tried to sustain itself by selling to homeowners and gardeners. It was unable to find another company to buy what was left. The company had just one full-time employee as of March, and two part-time employees, according to its annual report.
Author: Luke Timmerman
Luke is an award-winning journalist specializing in life sciences. He has served as national biotechnology editor for Xconomy and national biotechnology reporter for Bloomberg News. Luke got started covering life sciences at The Seattle Times, where he was the lead reporter on an investigation of doctors who leaked confidential information about clinical trials to investors. The story won the Scripps Howard National Journalism Award and several other national prizes. Luke holds a bachelor’s degree in journalism from the University of Wisconsin-Madison, and during the 2005-2006 academic year, he was a Knight Science Journalism Fellow at MIT.
View all posts by Luke Timmerman
